Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
Authors:
- Carla Riera-DomingoCRCarla Riera-Domingo
- Eduarda Leite-GomesELEduarda Leite-Gomes
- Iris CharatsidouICIris Charatsidou
- Giovanna CarráGCGiovanna Carrá
- Federica CappellessoFCFederica Cappellesso
- Maxim De SchepperMSMaxim De Schepper
- Dana LiuDLDana Liu
- Mohamad-Gabriel AlamehMAMohamad-Gabriel Alameh
- Vladimir V. ShuvaevVSVladimir V. Shuvaev
- 24 March 2023
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (12) , eadd5028
Abstract
Endothelial cells (ECs) grant access of disseminated cancer cells to distant organs. However, the molecular players regulating the activation of quiescent ECs at the premetastatic niche (PMN) remain elusive. Here, we find that ECs at the PMN coexpress tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) and its cognate death receptor 5 (DR5). Unexpectedly, endothelial TRAIL interacts intracellularly with DR5 to prevent its signaling and preserve a quiescent vascular phenotype. In absence of endothelial TRAIL, DR5 activation induces EC death and nuclear factor κB/p38–dependent EC stickiness, compromising vascular integrity and promoting myeloid cell infiltration, breast cancer cell adhesion, and metastasis. Consistently, both down-regulation of endothelial TRAIL at the PMN by proangiogenic tumor-secreted factors and the presence of the endogenous TRAIL inhibitors decoy receptor 1 (DcR1) and DcR2 favor metastasis. This study discloses an intracrine mechanism whereby TRAIL blocks DR5 signaling in quiescent endothelia, acting as gatekeeper of the vascular barrier that is corrupted by the tumor during cancer cell dissemination.Keywords
This publication has 69 references indexed in Scilit:
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie International Edition, 2012
- Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptorProceedings of the National Academy of Sciences, 2011
- TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammationJournal of Leukocyte Biology, 2011
- Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulationProceedings of the National Academy of Sciences, 2011
- Multiple functions of CXCL12 in a syngeneic model of breast cancerMolecular Cancer, 2010
- Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient miceBlood, 2008
- TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor developmentJournal of Clinical Investigation, 2008
- The Effects of mTOR-Akt Interactions on Anti-apoptotic Signaling in Vascular Endothelial CellsJournal of Biological Chemistry, 2007
- Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2Molecular and Cellular Biology, 2006
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999